Business23 Oct 2026
Pathos AI raises $237M at a $3B valuation in a round led by Bristol Myers Squibb
The AI drug-development company's Series E, led by Bristol Myers Squibb, arrives with a data-licensing tie-up involving Tempus AI.
News · Tag
bristol myers squibb
Every brief tagged bristol myers squibb, newest first.
More like this
Business6 Nov 2026
OpenAI gets first $11 billion of round at $1.25 trillion valuation
Business5 Nov 2026
Future Secure AI raises US$80 million at US$1.2 billion valuation
Related tags
Latest
No more news tagged bristol myers squibb for now. See all the latest news